Contact an Account ManagerEnantiomeric separation of the beta-blocking drugs pindolol and bopindolol using a chiral immobilized protein stationary phase
Summary
Type: HPLC
Application #: 105850
Catalog#: 720046.40 - MN HPLC Column, Resolvosil BSA-7, 300A, 7um, 4x150mm
Detection: 1) UV, 220nm
2) UV, 220nm
Conditions: 1) eluent: 0.1M Na2HPO4 + 0.1M NaH2PO4 + 0.5% isopropanol, flow rate 2ml/min
2) eluent: 0.1M Na2HPO4 + 5% isopropanol, flow rate 2ml/min
Authors: Küsters, E. et al.
Source: HRC 9 (1986) 531–533
Details
Legend: 1) Enantiomeric separation of bopindolol.
2) Enantiomeric separation of pindolol as isopropylcarbamatoylisopropylurea derivative.